Showing results (41-50 of 177) with videos related to

Sort By:
Pageof 18
Academic Radiology|July 8, 2014
Assessing treatment response of osteolytic lesions by manual volumetry, automatic segmentation, and RECIST in experimental bone metastasesMaren Bretschi, Andrea Fränzle, Maximilian Merz, et al.
Transplantation and Cellular Therapy|November 15, 2025
Belumosudil for Chronic Graft-Versus-Host Disease: A Systematic Review and Meta-AnalysisKristin Rathje, Nico Gagelmann, Silke Heidenreich, et al.
Bone Marrow Transplantation|December 5, 2024
Single versus tandem autologous stem cell transplantation in newly diagnosed multiple myelomaNora Grieb, Alexander Oeser, Maximilian Ferle, et al.
Annals of Hematology|April 15, 2017
Diagnosis and treatment of multiple myeloma in Germany: analysis of a nationwide multi-institutional surveyMaximilian Merz, Lenka Kellermann, Wolfram Poenisch, et al.
Transplantation and Cellular Therapy|June 4, 2025
Pilot Study of Low-Dose Splenic Irradiation and Transplantation in JAK Inhibitor-Refractory Myelofibrosis With SplenomegalyKristin Rathje, Nico Gagelmann, Artur Schneider, et al.
The Lancet. Haematology|April 11, 2024
Methodological challenges in the development of endpoints for myelofibrosis clinical trialsGiovanni Barosi, Ayalew Tefferi, Naseema Gangat, et al.
Transplantation and Cellular Therapy|May 7, 2026
A network meta-analysis of randomized trials to determine optimal GVHD prophylaxis in matched sibling donor transplantationGonzalo Bentolila, Nihar Desai, Shernan Holtan, et al.
Blood|June 12, 2025
Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRSTMaximilian Merz, Nico Gagelmann, Samih Smaili, et al.
European Journal of Haematology|August 26, 2019
Allogeneic stem cell transplantation in patients with myelofibrosis harboring the MPL mutationDaniele Mannina, Nico Gagelmann, Anita Badbaran, et al.
Bone Marrow Transplantation|October 14, 2024
Navigating 'grey areas' and challenges during evaluation of transplant eligibility in specific myelofibrosis populations: a perspective on behalf of the Chronic Malignancies Working Party of the EBMTNicola Polverelli, Juan Carlos Hernández-Boluda, Nico Gagelmann, et al.
Pageof 18